Disobutamide

This classification denotes an antiarrhythmic agent with the molecular formula C23H38ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 4IZG3M7XVP, chemically known as 1-piperidinebutanamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-(2-chlorophenyl)- but more generally known as disobutamide, which bears US NIH Compound Identifier 68566. European Medicines Agency schedules Disobutamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07234MIG. The term DISOBUTAMIDE is an International Non-Proprietary Name. DISOBUTAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule disobutamide under HS 29333999 and SITC 51574. As of Q4 2014, DISOBUTAMIDE remains US FDA's Preferred Term for this commodity. Disobutamide bears US NLM identifiers UMLS ID C0058462 and NCI Concept Code C81427. SMILES: CLC1C(C(CCN2CCCCC2)(CCN(C(C)C)C(C)C)C(=O)N)CCCC1.